This Pattern on Weight Loss Drugs Is 'Hard to Ignore'

Blockbuster weight-loss drugs may be doing more than shrinking waistlines—they could be slowing cancer, too. Four observational studies suggest patients on GLP-1 medications such as Ozempic and Mounjaro had slower tumor growth, were less likely to see early-stage cancers advance, and in some cases were less likely to develop...